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ABSTRACT
Background Oxidative stress is proposed as an 
important factor in osteoarthritis (OA).
Objective To investigate the expression of the three 
superoxide dismutase (SOD) antioxidant enzymes in OA.
Methods SOD expression was determined by real-time 
PCR and immunohistochemistry using human femoral 
head cartilage. SOD2 expression in Dunkin–Hartley 
guinea pig knee articular cartilage was determined by 
immunohistochemistry. The DNA methylation status of 
the SOD2 promoter was determined using bisulphite 
sequencing. RNA interference was used to determine the 
consequence of SOD2 depletion on the levels of reactive 
oxygen species (ROS) using MitoSOX and collagenases, 
matrix metalloproteinase 1 (MMP-1) and MMP-13, gene 
expression.
Results All three SOD were abundantly expressed 
in human cartilage but were markedly downregulated 
in end-stage OA cartilage, especially SOD2. In the 
Dunkin–Hartley guinea pig spontaneous OA model, 
SOD2 expression was decreased in the medial tibial 
condyle cartilage before, and after, the development 
of OA-like lesions. The SOD2 promoter had signifi cant 
DNA methylation alterations in OA cartilage. Depletion 
of SOD2 in chondrocytes increased ROS but decreased 
collagenase expression.
Conclusion This is the fi rst comprehensive expression 
profi le of all SOD genes in cartilage and, importantly, 
using an animal model, it has been shown that a 
reduction in SOD2 is associated with the earliest stages 
of OA. A decrease in SOD2 was found to be associated 
with an increase in ROS but a reduction of collagenase 
gene expression, demonstrating the complexities of ROS 
function.
INTRODUCTION
Osteoarthritis (OA) is a common degenerative 
joint disease characterised by focal degradation of 
articular cartilage, centred on loadbearing areas. 
The primary risk factor for OA development is age, 
but the mechanisms by which ageing contributes 
to OA susceptibility and progression remain poorly 
understood. Articular cartilage extracellular matrix 
(ECM), which is maintained by chondrocytes, 
undergoes signiﬁ cant changes in structure and 
composition with age, closely linked to a decline 
in chondrocyte function.1 2 Many studies have 
 identiﬁ ed molecular characteristics of ageing in OA 
cartilage or chondrocytes which may contribute 
to the onset of OA, including telomere genomic 
 instability, formation of advanced glycation end 
products, increased apoptosis and senescence.3 
Many such changes could be associated with 
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the elevated levels of oxidative stress that occur 
in OA and aged cartilage,4 leading to an altered 
 chondrocyte  phenotype that renders cells unable 
to respond effectively to normal loading regimens5 
and potentially contributes to disease onset.
Although generally considered a hypoxic 
environment, oxygen diffuses through articular 
cartilage and is used by chondrocytes to derive 
approximately 25% of their ATP. Oxidative phos-
phorylation is a major source of reactive oxy-
gen species (ROS); however, chondrocytes also 
express NADPH oxidase and nitric oxide (NO) 
synthase family members together with various 
oxygenases which principally generate the ROS 
NO and the superoxide anion (O2
•−).4 These ROS 
generate derivatives including hydrogen peroxide 
(H2O2), peroxynitrite (ONOO
−) and hydroxyl rad-
icals (OH•). ROS are highly reactive and therefore 
transient so their production in cartilage has been 
determined indirectly; an accumulation of lipid 
peroxidation products6 and nitrotyrosine resi-
dues7 have been observed in aged and OA carti-
lage. ROS can cause cartilage degradation directly 
by cleaving collagen and aggrecan and activating 
matrix metalloproteinases (MMP),8–10 a family of 
enzymes that have a key role in cartilage destruc-
tion in OA.11 ROS also act indirectly by modu-
lating redox-sensitive signalling pathways that 
control MMP expression, and in cultured chondro-
cytes may lead to decreased collagen and aggrecan 
synthesis.12 13
To prevent an accumulation of ROS-mediated 
damage chondrocytes produce a number of 
antioxidant enzymes, including the  superoxide 
dismutases (SOD), catalase and glutathione 
 peroxidase.4 There are three SOD family  members; 
SOD1 (Cu/Zn-SOD) found principally in the 
 cytosol, SOD2 (Mn-SOD) found in the mitochon-
drial matrix and SOD3 (EC-SOD) found in the 
ECM. The SOD family catalyses the  dismutation 
of O2
•− to O2 and H2O2, thereby limiting the for-
mation of highly aggressive compounds such as 
ONOO− and OH•.
SOD2 has been shown to be downregulated in 
OA cartilage.14 15 SOD3 is also decreased in human 
OA cartilage and in a mouse model of OA.16 SOD3-
deﬁ cient mice show an increased severity of colla-
gen-induced arthritis.17 Together, these and other 
data have led to the proposal that supplementary 
antioxidants may represent a potential treatment 
for OA.18
We considered that the SOD family may have 
a key role in controlling ROS levels in cartilage 
and that any deﬁ ciency may account for the 
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elevated oxidative stress observed. Here, we report a signiﬁ -
cant decrease in the expression of all SOD family members in 
OA cartilage compared with macroscopically normal cartilage 
(from patients with a neck of femur (NOF) fracture) at both 
the RNA and protein levels. We also show that the decline in 
SOD2 expression correlates with the onset of, and importantly 
precedes, OA-like lesions in an animal model. We also dem-
onstrate that the SOD2 promoter is signiﬁ cantly differentially 
methylated in OA compared with NOF cartilage, representing 
a potential mechanism for the reduction in expression seen in 
OA. Functionally, SOD2 depletion in chondrocytes resulted in 
a signiﬁ cant increase in ROS but a decrease in the interleu-
kin (IL)1-induced levels of MMP-1 and MMP-13. Together, our 
data suggest that a decrease in SOD2 expression may be pre-
symptomatic of disease and potentially an attempt to reduce 
the expression of collagenases, enzymes which contribute to 
cartilage degradation, but concomitantly also contributes to 
increased oxidative stress.
MATERIALS AND METHODS
Materials
Antibodies against SOD1 and SOD2 were from Stressgen 
Bioscience (Cambridge, UK) and SOD3 from Abcam (Cambridge, 
UK). Rabbit immunoglobulin G (IgG) isotype control  antibody, 
oligonucleotides (table 1), PCR Mastermix and 5-aza-2′-
deoxycytidine (AZA) were from Sigma-Aldrich (Poole, UK). 
Anti-rabbit Vectastain ABC Elite kit and Vectashield were from 
Vector Laboratories (Peterborough, UK). Recombinant human 
IL1α was a gift from GlaxoSmithKline (Stevenage, UK). Taqman 
Low Density Arrays (TLDA) were from Applied Biosystems 
(ABI, Foster City, California, USA). Sybr-Green Mastermix 
was from Invitrogen (Paisley, UK). SmartPool small interfering 
RNA (siRNA) against SOD2 (table 1) and siControl2 were from 
Dharmacon (Cramlington, UK).
RNA extraction from cartilage samples, 
chondrocyte isolation and cell culture
Articular cartilage was obtained from patients undergoing joint 
replacement surgery. Hip cartilage samples from patients with 
OA were compared with lesion-free cartilage from patients 
with fracture to the NOF with no known history of joint dis-
ease. Femoral heads were processed and RNA extracted using 
established methodology.19 Human articular chondrocytes 
(HACs) were isolated from OA cartilage and cultured as previ-
ously described.20 This study was performed with ethical com-
mittee approval from Norfolk and Norwich University Hospital 
Trust, Oxford Radcliffe Hospitals NHS Trust and Newcastle 
and North Tyneside Health Authority and all patients provided 
informed consent.
Real-time RT-PCR and siRNA-mediated gene silencing
RNA interference (RNAi) in HACs was as previously described19 
with the siRNA used at 100 nmol/l. Brieﬂ y, 2.5 × 104/cm2 (HAC) 
cells were seeded overnight and the following day transfected 
with Dharmafect 1 (Dharmacon) and siRNA (SOD2 (table 1) 
or non-targeting control, siControl2). Cells were washed 24 h 
after transfection with phosphate-buffered saline (PBS) and 
cultured in serum-free medium for a further 24 h before 24 h 
stimulation±0.05 ng/ml IL1, or as described. Total RNA was 
isolated using the Cells-to-cDNA II Kit (ABI) and MMP-1 
and MMP-13 expression determined by real-time RT-PCR, 
as  previously described.19 Gene depletion was conﬁ rmed by 
 real-time RT-PCR and immunoblotting of total cell lysates pre-
pared as described.19 SOD family gene expression in cartilage 
cDNA was assessed using a TLDA according to the manu-
facturer’s (ABI) instructions and as previously described.19 
Throughout, mRNA levels were normalised to a housekeeping 
gene (ABI) using the calculation 2−ΔCt.
Immunohistochemistry
Human patient samples
Serial sections (12 μm) were prepared and processed from full-
depth cartilage taken from intact cartilage of OA and NOF 
femoral heads, as previously described.21 Serial sections were 
incubated for 60 min at room temperature (RT) with either a 
polyclonal primary (rabbit) antibody to a SOD or a normal rab-
bit IgG isotype-matched control. All antibodies were used at a 
concentration of 1 μg/ml except for SOD3 which was used at a 
1:2000 dilution. All antibodies were prepared in PBS containing 
1.5% (v/v) normal goat serum.
Dunkin Hartley guinea pig knee samples
Male Dunkin–Hartley guinea pigs (Harlan Olac, UK) aged from 
1 to 8 months (ﬁ ve per group) were used for histology. Animals 
were humanely killed according to UK Home Ofﬁ ce regula-
tions. Tibial heads were ﬁ xed in 4% (v/v) formaldehyde for 2 
days and decalciﬁ ed in 0.1 mol/l EDTA (pH 7.0) in PBS for 3 
weeks. Blocks that included articular cartilage and bone (lat-
eral and medial tibial plateaus) were dehydrated and embedded 
in parafﬁ n. Serial, coronal sections (5 μm) were deparafﬁ nised 
with xylene and rehydrated through a graded ethanol series 
and, ﬁ nally, incubated in 10 mmol/l sodium citrate buffer, pH 
6.0, for 2 h at RT, followed by 3% (v/v) H2O2 in Tris-buffered 
saline (TBS) for 15 min. Serial sections were blocked with 1.5% 
(v/v) normal goat serum in TBS for 30 min and then incubated 
Table 1 Oligonucleotides: real-time RT-PCR, bisulphite PCR primers and superoxide dismutase 2 (SOD2) 
siGENOME SMART pool siRNA sequences
Gene Method Primer Sequence
SOD2 Sybr Green RT-PCR Forward
Reverse
5′-CTGGACAAACCTCAGCCCTA
5′-TGATGGCTTCCAGCAACTC
SOD2 DNA methylation analysis Forward
Reverse
5′-GTAATTAAAATTTAGGGGTAGG
5′-AAAAAAAACTACAAACTAACCTC
SMARTpool Duplex Target strand Sequence
1 Sense
Antisense
5′-GGACAAACCUCAGCCCUAAUU
5′-PUUAGGGCUGAGGUUUGUCCUU
2 Sense
Antisense
5′-GGAGCACGCUUACUACCUUUU
5′-PAAGGUAGUAAGCGUGCUCCUU
3 Sense
Antisense
5′-AAAGAUACAUGGCUUGCAAUU
5′-PUUGCAAGCCAUGUAUCUUUUU
4 Sense
Antisense
 5′-GUAAUCAACUGGGAGAAUGUU
5′-PCAUUCUCCCAGUUGAUUACUU
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10–15 ng bisulphite-treated gDNA using Titanium Taq (TaKaRa 
Biomedicals, Wokingham, UK). PCR conditions were 95°C 
1 min, (95°C 15 s, 64.2°C 30 s, 68°C 1 min) × 40 cycles, 68°C 
for 7 min. PCR products were cloned and DNA sequenced until 
10 unique clones from each patient sample were obtained. 
DNA methylation analysis was performed using the BiQ ana-
lyzer software.23
Statistical analysis
Differences between NOF and OA groups and cultured cell 
treatments were deﬁ ned using a two-tailed Mann–Whitney U 
test. Fisher’s exact test was used for statistical analysis of DNA 
methylation. Student t-tests were performed when quantifying 
the level of immunological or MitoSOX staining.
RESULTS
The SOD gene family are highly but differentially expressed 
between NOF and OA human cartilage
A screen for SOD expression found that all three genes have 
signiﬁ cantly reduced expression in OA compared with NOF 
cartilage. The median expression levels of SOD1, SOD2 and 
SOD3 were reduced 3.4- (p=0.0014), 41.5- (p≤0.0001) and 
3.9- (p=0.0009) fold, respectively, in OA cartilage. This reduc-
tion in SOD2 and SOD3 expression compares with previous 
reports.14 16 The quantitative nature of this screen disclosed the 
very high abundance of all the SOD family, particularly SOD2, 
with the relative abundance of each in NOF samples being: 
SOD2>>SOD3>actin B (ACTB)>SOD1 (ﬁ gure 1).
To validate our RNA expression data we performed immu-
nohistochemistry using OA and NOF cartilage (ﬁ gure 2A). As 
expected SOD1 expression was cellular with staining obvious 
throughout the sections (ie, from articular surface to subchon-
dral bone), though staining was more intense at the articular 
surface. Staining within the full-depth cartilage was signiﬁ cantly 
reduced in OA sections (ﬁ gure 2B). SOD2 staining was cellular 
and strongest near the articular surface. There was a clear, sig-
niﬁ cant, decrease in the expression of SOD2 in the surface zones 
of the diseased tissue though the protein was still detected. A 
SOD3 antibody gave the expected diffuse staining pattern rep-
resentative of ECM staining. This was visible throughout the 
tissue, though staining was more intense at the articular sur-
face and again signiﬁ cantly reduced in OA compared with NOF 
cartilage.
for 90 min at RT with an antibody to SOD2 or normal rab-
bit IgG (1 μg/ml in TBS/1.5% (v/v) normal goat serum). The 
remainder of the staining procedure and mounting was per-
formed as previously described.21 Representative sections from 
each animal were stained with safranin ‘O’/fast green (0.02% 
(w/v) fast green for 3 min, 1% (v/v) acetic acid for 30 s, 0.1% 
(w/v) safranin ‘O’ for 5 min).
MitoSOX Red staining
HACs were transfected with siRNA against SOD2 or a control 
(see above) and 24 h later serum starved overnight. Cells were 
then stained with 2 μmol/l MitoSOX Red (Invitrogen) in serum-
free media for 15 min at 37°C, washed twice in PBS for 5 min 
and ﬁ xed in 4% (w/v) cold paraformaldehyde in PBS for 10 min 
at RT or, for SOD2 staining, permeabilised and blocked with 
0.5% (v/v) Saponin/PBG (0.5% (w/v) BSA solution/0.2% (v/v) 
ﬁ sh skin gelatin) in PBS for 10 min at RT, incubated with 1 μg/
ml rabbit anti-human SOD2 antibody in 0.5% Saponin/PBG for 
45 min at RT, washed twice with 0.5% Saponin/PBG and then 
incubated with secondary antibody (goat anti-rabbit Alexa 488) 
(1:750 in 0.5% Saponin/PBG) for 45 min at RT, before ﬁ xing as 
above. All slides were washed twice with PBS and mounted in 
Vectashield and visualised using confocal microscopy.
Image analysis
Fluorescent and immunohistochemical images were analysed 
using ImageJ analysis software (Wayne Rasband, NIH, USA). 
For ﬂ uorescent images, individual cells from random ﬁ elds 
were selected and the average red (MitoSOX Red) and/or green 
(SOD2) pixels present in the cell (per area) calculated after aver-
age background subtraction. Immunological staining from carti-
lage sections was quantiﬁ ed for each section area for SOD3 or 
on a per cell basis for SOD1 and SOD2.
DNA methylation analysis
HACs were cultured±10 μmol/l AZA for 35 days before RNA 
isolation, with fresh AZA added daily. SOD2 expression was 
determined by real-time RT-PCR. Genomic DNA (gDNA) 
was puriﬁ ed from cartilage samples during RNA extraction22 
by ethanol precipitation of the ﬁ rst wash of Qiagen RNeasy 
columns (Qiagen, Crawley, UK). gDNA (200–300 ng) was 
treated with bisulphite using the Epitect Bisulﬁ te kit (Qiagen). 
PCR was performed to amplify a SOD2 promoter region from 
Figure 1 Comparison of superoxide dismutase (SOD) gene expression between cartilage from neck of femur (NOF) and patients with osteoarthritis 
(OA). SOD family gene expression was determined by real-time reverse transcriptase PCR from cartilage RNA isolated from 12 NOF (open) and 12 
patients with OA (shaded). Gene expression data are presented as a ratio of SOD gene levels to that of the housekeeping gene, actin B (ACTB), using 
the calculation 2−∆Ct. Lines within the boxes represent the median, the boxes represent the 25th and 75th centiles, and the lines outside the boxes 
correspond to the minimum and maximum values. The p values were calculated using the Mann–Whitney U test: **p<0.01; ***p<0.001.
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Figure 2 Immunohistochemical analysis of superoxide dismutase (SOD) expression in representative specimens of human articular cartilage from neck 
of femur (NOF) and patients with osteoarthritis (OA). (A) Sections were subjected to immunohistochemistry using the labelled anti-SOD or normal rabbit 
IgG (negative control) and counterstained with haematoxylin. Full-depth sections are shown at ×5 magnifi cation and for clarity the articular surface is 
shown at ×20. Images are representative of sections from fi ve NOF and fi ve patients with OA. (B) Immunohistochemical images, of fi xed exposure, from 
fi ve NOF and fi ve patients with OA were quantifi ed using the ImageJ software. For each image the percentage staining in each fi eld of view (FOV) was 
calculated and the mean with standard error of the mean (SEM) NOF and OA FOV presented. Percentage FOV was calculated for full-depth sections or 
after dividing the section into two quadrants ‘deep’ and ‘surface’. p Values were calculated using the Student t test,: *p<0.05; **p<0.01.
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SOD2 expression declines before the appearance of OA erosions
Since the changes in SOD2 expression were most signiﬁ cant, 
we next ascertained its expression during the onset of OA using 
joint sections from Dunkin–Hartley guinea pigs of different 
ages; an established model of spontaneous OA.24 In this model 
the medial tibial plateau develops OA-like lesions as the animal 
ages, while the lateral tibial plateau develops signiﬁ cantly fewer 
lesions as highlighted by cellular and surface changes together 
with a decrease in safranin ‘O’ staining, representative of pro-
teoglycan loss (ﬁ gure 3A). In young animals (1 month) SOD2 
staining was strongest near the articular surface of both medial 
and lateral plateaus (ﬁ gure 3A), as observed in human NOF car-
tilage (ﬁ gure 2). At 4 months of age OA-like lesions could be 
seen on the medial but not lateral plateau. Concomitantly SOD2 
expression was signiﬁ cantly reduced in the diseased medial, but 
not the normal lateral plateau (ﬁ gure 3A,B). Interestingly, SOD2 
expression within the medial plateau signiﬁ cantly declined 
before observation of lesions (ie, in 2-month-old animals), sug-
gesting that this change in expression may be symptomatic of 
early changes in OA (ﬁ gure 3A,B).
The SOD2 promoter is differentially methylated between NOF 
and OA cartilage
As SOD2 promoter hypermethylation correlates with decreased 
gene expression (eg, Hurt et al25), we investigated the part that 
DNA promoter methylation may play in the SOD2 downreg-
ulation seen in OA chondrocytes. First, we found that SOD2 
expression increased twofold (p≤0.001) in OA HAC treated with 
Figure 3 Immunohistochemical analysis of superoxide dismutase 2 (SOD2) expression in representative specimens of Dunkin–Hartley guinea pig 
articular cartilage. (A) Cartilage sections are representative of fi ve animals at each time point (1–8 months of age). Sections were either stained 
with safranin ‘O’ as a marker of proteoglycan or subjected to immunohistochemistry using the labelled anti-SOD2 or normal rabbit IgG (negative 
control—data not shown). Lateral and medial tibial plateaus are as indicated. Images shown are at ×10 magnifi cation, unless indicated otherwise. 
(B) Immunohistochemical images of lateral and medial tibial plateaus, of fi xed exposure, from fi ve animals were quantifi ed using the ImageJ software. 
For each image the percentage staining in each fi eld of view (FOV) was calculated. For each age group the staining in the lateral plateau is arbitrarily 
100% + SEM. p Values were calculated using the Student t test,: *p<0.05; **p<0.01.
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the DNA demethylating agent, AZA (ﬁ gure 4A), indicating a role 
for DNA methylation in SOD2 regulation. Next, we analysed 
a region of the SOD2 promoter upstream of the  transcription 
start site at −297 to −87 (online supplementary ﬁ gure 1) known 
to be subject to differential methylation.25 Bisulphite sequenc-
ing of, on average, 9.6 clones from each of 12 OA and NOF 
patient cartilage samples identiﬁ ed three CpG sites, CpG6, 10 
and 14, corresponding to nucleotides −222, −183 and −154, 
respectively, with signiﬁ cant differences in methylation status 
between NOF and OA cartilage (ﬁ gure 4B). CpG14 and CpG10 
showed signiﬁ cantly (p≤0.001 and p≤0.05, respectively) lower 
methylation in OA cartilage, whereas CpG6 was more methy-
lated (p≤0.001) in OA cartilage. CpG14 is encompassed within 
a putative AP-2 binding site while CpG10 is located at a single 
Figure 4 Analysis of the regulation of superoxide dismutase 2 (SOD2) in human articular chondrocytes (HAC) by DNA methylation. (A) Primary 
HAC were treated with the DNA demethylating agent 5-aza-2’deoxycytidine (AZA) for 35 days (two passages) as described and SOD2 expression 
measured by real-time RT-PCR and normalised to glyceraldehyde 3-phosphate dehydrogenase (GAPDH) expression levels. Data are presented fold over 
control and error bars represent SEM. Data are combined from four HAC populations treated in duplicate. Statistical signifi cance was calculated using 
the Mann–Whitney U test: ***p<0.001. (B) DNA methylation analysis of the SOD2 promoter in cartilage genomic DNA from neck of femur (NOF) and 
patients with osteoarthritis (OA). Genomic DNA from cartilage of 12 NOF and 12 patients with OA was analysed to determine the methylation status 
of the SOD2 promoter region spanning 19 potential CpG dinucleotides. An average of 9.6 non-clonal DNA sequences per patient sample were analysed 
and the methylation percentage for each is plotted. Methylation CpG sequences are represented by black bars, open are non-methylated and the bar 
is grey when the CpG sequence was not detected, generally owing to a single nucleotide polymorphism at that locus (eg, CpG10). Fisher’s exact test 
was used for statistical analysis: *p<0.05; **p<0.01.
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nucleotide polymorphism (NCBI reference rs2758343). Overall, 
OA cartilage had, as hypothesised, a signiﬁ cant increase (p≤0.05) 
in methylated CpG.
SOD2 depletion modulates MMP-1 and 
MMP-13 expression in HAC
A reduction in SOD levels is likely to lead to an increase in 
ROS. Since SOD2 is localised to the mitochondria, the major 
source of ROS, we used the mitochondria-targeting MitoSOX 
Red, which is oxidised by O2
•−, but not other ROS or reactive 
nitrogen species, to conﬁ rm that SOD2 depletion increased O2
•− 
levels in chondrocytes (ﬁ gure 5A, B). A further consequence 
of a reduction in SOD2 is a decrease in H2O2 which acts as 
an intracellular signalling moiety.26 Hence, we tested whether 
a reduction in SOD2 in chondrocytes would effect basal and 
proinﬂ ammatory cytokine (IL1)-induced collagenase (MMP-1 
and MMP-13) expression. RNAi depletion of SOD2 in chon-
drocytes (ﬁ gure 5C) resulted in a signiﬁ cant reduction of basal 
MMP-1 but not MMP-13 expression (ﬁ gure 5D). OA has an 
inﬂ ammatory component27 and IL1, a potent inducer of SOD2 
and the collagenases, can be detected within the OA joint. In 
line with this, IL1 stimulation led to a robust increase in SOD2 
and collagenase expression. However, depletion of SOD2 
 signiﬁ cantly decreased the IL1-induced expression of both col-
lagenases (ﬁ gure 5E).
DISCUSSION
Here, we found that all of the SOD family of antioxidant 
enzymes are highly expressed in NOF human cartilage in rela-
tion to an established housekeeping gene, which suggests that 
cartilage must generate signiﬁ cant levels of ROS and that ROS 
scavenging is necessary for tissue maintenance and homoeosta-
sis.28 Our ﬁ ndings show that expression of all SOD enzymes 
is signiﬁ cantly reduced in diseased cartilage, conﬁ rming and 
expanding on previous data for SOD2 and SOD3.14–16 Regan et 
al, found that SOD3 was reduced in OA compared with normal 
(again, hip fracture) human tissue and in the cartilage of the STR/
ort mouse spontaneous OA model, interestingly also before his-
tological evidence of disease.16 SOD3 levels in synovial ﬂ uid are 
also reduced in patients with OA compared with patients with 
injured/painful joints but no cartilage damage.29 We have now 
shown that SOD2 expression is signiﬁ cantly downregulated in 
OA chondrocytes in vivo, and that this precedes the develop-
ment of OA lesions in the Hartley guinea pig, raising the pos-
sibility that alterations in SOD2 expression are associated with 
the earliest stages of OA pathogenesis.
SOD2 expression is subject to epigenetic control via pro-
moter DNA methylation in a number of carcinoma cell lines.25 
Furthermore, aberrant DNA methylation occurs with disease 
and ageing.30 In chondrocytes, SOD2 expression increased after 
inhibition of DNA methylation (ﬁ gure 4A) and analysis of the 
SOD2 promoter identiﬁ ed a signiﬁ cant overall increase in the 
number of CpG sites partially methylated in OA compared with 
NOF cartilage (ﬁ gure 4B). Promoter DNA methylation is gener-
ally repressive to transcription, thus even the modest increase 
in CpG methylation seen here may signiﬁ cantly impact on the 
SOD2 expression level. Reinstigation of SOD2 expression using 
DNA methyltransferase inhibitors is one way in which they 
may beneﬁ t patients with OA, as proposed.31
SOD are required for the conversion of reactive O2
•− to O2 and 
H2O2 and thus a downregulation of SOD would increase oxida-
tive stress, which is implicated in a number of disease, including 
arthritis.32 Thus, research has investigated the consequences of 
modulating SOD levels in both cells and animal models. SOD1 
and SOD3 knockout mice display relatively mild phenotypes33 
but exhibit an increase in oxidative stress markers.34 SOD2 dele-
tion in mice results in lethality by neonatal day 10.35 SOD2 is 
localised to the mitochondria and dismutates O2
• produced as a 
by-product of oxidative phosphorylation. It has been proposed 
that depletion of SOD2 leads to increased mitochondrial DNA 
mutation and subsequent dysfunction. Interestingly, mitochon-
drial DNA mutations increase in OA,36 and mitochondrial DNA 
haplogroups themselves contribute to the pathogenesis of OA.37
The combined effect of a decrease in all three SOD enzymes 
could signiﬁ cantly contribute to the increased oxidative stress 
found in OA cartilage.38 Using RNAi we conﬁ rmed that deple-
tion of SOD2 from chondrocytes leads to an increase in O2
•−, 
which can result in telomere instability and a downregulation 
of chondrocyte function38 as well as damage to cartilage mac-
romolecules such as hyaluronan and collagen.9 39 An increase 
in ROS could also potentially contribute to the onset of senes-
cence, which may have a role in OA.1 Together, these and other 
data suggest that SOD may have a protective role in the joint 
and cartilage. However, the results here demonstrate that down-
regulation of SOD2 is, in part, chondroprotective, reducing the 
activation of redox-sensitive signalling pathways and thus col-
lagenase expression. Similarly, in ﬁ broblasts, SOD2 overexpres-
sion increases MMP-1 expression via increased H2O2-dependent 
activation of ERK1/240 and AP-1,41 while SOD2-deﬁ cient ﬁ bro-
blasts cannot induce MMP-1 and MMP-13 after cytokine stimu-
lation.40 It is therefore perhaps unsurprising that the depletion 
of SOD2 in HACs resulted in a decrease in basal MMP-1, an 
observation seen in end-stage OA,22 as well as a decrease in pro-
duction of both collagenases after IL1 stimulation (ﬁ gure 5), pre-
sumably by reduced H2O2 levels. H2O2 levels are also controlled 
by catalase, whose expression we found to be signiﬁ cantly 
increased in OA cartilage (data not shown); indeed, increased 
catalase expression can reverse the H2O2-mediated induction 
of MMP-1 in ﬁ broblasts.40 Therefore one potential beneﬁ t of a 
downregulation in SOD2 would be to reduce the expression of 
matrix-degrading enzymes by modulation of redox-controlled 
signalling pathways. However, the role of ROS is complex and 
increased levels can actually activate latent MMP,8 while more 
aggressive ROS such as ONOO−, generated from O2
•− and NO, 
can also modulate redox-sensitive signalling pathways.42 As a 
result, elucidation of the overall consequences of SOD2 down-
regulation requires more detailed analysis of both the levels of 
O2
•− present in NOF and OA chondrocytes and the activity of 
the associated redox-sensitive signalling pathways.
Several studies have used antioxidants as treatments for 
arthritis (reviewed by Afonso et al18). Ex vivo SOD3 gene trans-
fer or SOD mimetics (eg, M40403) can reduce the severity of 
collagen-induced arthritis in models,43 44 and recombinant 
SOD1 can inhibit cartilage damage in hens. A trial of intra-ar-
ticular injections of bovine SOD1 (Orgotein) has also been car-
ried out in patients with OA with some success; however, the 
drug was withdrawn owing to adverse side effects (reviewed 
by Afonso et al18). As dietary supplements, vitamins have been 
shown to decrease OA development and increase the expres-
sion of antioxidant enzymes in an OA model.18 However, 
 epidemiological studies examining the beneﬁ ts of antioxidants 
in human OA, especially vitamin E (α-tocopherol), are contra-
dictory (reviewed by Henrotin et al4).
In conclusion, this is the ﬁ rst detailed study to examine the 
expression of all three SOD antioxidant enzymes in cartilage 
and OA. Our data clearly show a decrease in the expression 
of all three enzymes in OA cartilage, with SOD2 and SOD3 
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Figure 5 Functional consequences of superoxide dismutase 2 (SOD2) depletion. (A) and (B) SOD2 depletion (green) by RNA interference (RNAi) led 
to a signifi cant increase in MitoSOX Red mitochondrial staining as determined by confocal microscopy. Data are taken from four patient chondrocyte 
preparations. Images were quantifi ed using ImageJ software on a per cell basis from random fi eld images. p Values were calculated using a Student 
t test: **p<0.01; ***p<0.001. (C–E) Depletion of SOD2 leads to reduction in collagenase gene expression. (C) Transfection of primary human 
articular chondrocytes (HAC) from patients with OA with siRNA to SOD2 (siSOD2) for 48 h under basal conditions (24 h serum free) compared with 
transfection with an equivalent amount (100 nmol/l) of a non-targeting control siRNA (siCon) resulted in a highly signifi cant ~80% reduction in SOD2 
RNA level as determined by real-time RT-PCR. Concomitantly, a substantial reduction in SOD2 protein expression was measured by immunoblotting 
(an anti-glyceraldehyde 3-phosphate dehydrogenase antibody was used as a protein loading control). (D) Matrix metalloproteinase (MMP)-1 and 
MMP-13 basal expression levels were measured as described above. SOD2 RNAi resulted in a signifi cant reduction in MMP-1 but no change in 
the levels of MMP-13. (E) Interleukin 1 (IL1, 0.05 ng/ml) stimulation for 24 h induced the expression of SOD2, MMP-1 and MMP-13; however, the 
induced-expression of all three genes was signifi cantly reduced when SOD2 was depleted by RNAi (siSOD2). Throughout, RNA expression levels 
were normalised to the 18S gene and data plotted as fold over control levels. Data presented are from a single experiment (n=8) using cells from one 
donor. The experiment was performed three times using different patient cell populations. p Values were calculated using the Mann–Whitney U test: 
*p<0.05; **p<0.01; ***p<0.001. Error bars shown are SEM.
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expression decreasing before the appearance of histologically 
detectable lesions. ROS are normal and useful metabolites, serv-
ing important roles in a number of processes, including their 
action as a signalling molecule. Depletion of SOD2 reduced 
the IL1-induced expression of MMP-1 and MMP-13, indicat-
ing that the decrease of SOD2 expression in OA cartilage may 
represent a chondroprotective mechanism. However, SOD2 
depletion also leads to an increase in ROS and such an over-
production, as occurs in injury, disease or ageing, can lead to 
cell dysfunction and death.32 Clearly, the balance of ROS levels 
and the consequences of altered levels on cartilage are complex. 
Further work is required to determine whether the decrease in 
antioxidant enzymes reported here is an attempt by the joint to 
reduce cartilage destruction, mediated by modulating the levels 
of the collagenases but which ultimately leads to an increase 
in ROS and loss of cartilage homoeostasis. Such information is 
pertinent if antioxidant treatments hold the key to potential OA 
treatments.
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